Plasmapheresis may be considered as a therapeutic option for very severe hypertriglyceridemia that is refractory to conventional pharmacological therapy.
May support plasmapheresis consideration in refractory hypertriglyceridemia; hypothesis-generating case report requiring prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Miulescu et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: